ATA901688A - Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel - Google Patents
Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittelInfo
- Publication number
- ATA901688A ATA901688A AT0901688A AT901688A ATA901688A AT A901688 A ATA901688 A AT A901688A AT 0901688 A AT0901688 A AT 0901688A AT 901688 A AT901688 A AT 901688A AT A901688 A ATA901688 A AT A901688A
- Authority
- AT
- Austria
- Prior art keywords
- cyanoprostacycline
- cyclodextrinclathrate
- derivatives
- medicinal product
- medicinal
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873740838 DE3740838A1 (de) | 1987-11-27 | 1987-11-27 | Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA901688A true ATA901688A (de) | 1993-03-15 |
AT396687B AT396687B (de) | 1993-11-25 |
Family
ID=6341738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0901688A AT396687B (de) | 1987-11-27 | 1988-11-25 | Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US5010065A (de) |
EP (1) | EP0349621A1 (de) |
JP (1) | JPH02502379A (de) |
AT (1) | AT396687B (de) |
BE (1) | BE1001327A3 (de) |
CH (1) | CH677790A5 (de) |
DE (1) | DE3740838A1 (de) |
FR (1) | FR2623807B1 (de) |
GB (1) | GB2231045B (de) |
IT (1) | IT1227576B (de) |
WO (1) | WO1989004828A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227372A (en) * | 1990-03-07 | 1993-07-13 | Children's Medical Center Corporation | Method for retaining ophthalmological agents in ocular tissues |
DE4104607A1 (de) * | 1991-02-12 | 1992-08-13 | Schering Ag | Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen |
DE4135193C1 (de) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
US5694021A (en) * | 1994-02-28 | 1997-12-02 | Kabushiki Kaisha Toshiba | System for executing charge control of a secondary battery and detecting the capacitance thereof |
US5896596A (en) * | 1997-10-22 | 1999-04-27 | Nitto Kogyo Co., Ltd. | Apparatus for generating massaging water stream |
JP2009543826A (ja) * | 2006-07-18 | 2009-12-10 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 自己免疫疾患治療剤としての5−シアノ−プロスタサイクリン誘導体 |
WO2008058766A1 (en) | 2006-11-16 | 2008-05-22 | Bayer Schering Pharma Aktiengesellschaft | Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
CN102655859A (zh) | 2009-10-14 | 2012-09-05 | 格穆斯药业股份有限公司 | 病毒感染的组合疗法治疗 |
KR20220147691A (ko) | 2013-08-09 | 2022-11-03 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス, インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU64511B (en) * | 1911-03-14 | 1912-01-09 | Stephen Henry Watts Cooper | Improvements relating to cultivator shares |
JPS503362B1 (de) * | 1970-06-10 | 1975-02-04 | ||
DE2405146A1 (de) * | 1974-01-31 | 1975-08-07 | Siemens Ag | Mengenmessgeraet mit einem in einer kammer angeordneten rotor |
HU179141B (de) * | 1977-09-23 | 1982-08-28 | ||
DE2753244A1 (de) * | 1977-11-25 | 1979-06-07 | Schering Ag | Neue prostacyclinderivate und verfahren zu ihrer herstellung |
GB2017699B (en) * | 1978-03-31 | 1983-01-12 | Ono Pharmaceutical Co | 6,9-methano-pgi2 analogues |
JPS5540923A (en) * | 1978-09-14 | 1980-03-22 | Ono Sokki Co Ltd | Flow meter |
JPS56150039A (en) * | 1980-04-22 | 1981-11-20 | Sankyo Co Ltd | Clathrate compound of prostacycline derivative |
DE3448257C2 (en) * | 1984-07-25 | 1988-08-18 | Schering Ag, 1000 Berlin Und 4709 Bergkamen, De | Cytoprotective action of prostacyclin derivatives on the kidney |
DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
-
1987
- 1987-11-27 DE DE19873740838 patent/DE3740838A1/de not_active Ceased
-
1988
- 1988-11-25 AT AT0901688A patent/AT396687B/de not_active IP Right Cessation
- 1988-11-25 WO PCT/DE1988/000739 patent/WO1989004828A1/de not_active Application Discontinuation
- 1988-11-25 JP JP1500019A patent/JPH02502379A/ja active Pending
- 1988-11-25 CH CH2864/89A patent/CH677790A5/de not_active IP Right Cessation
- 1988-11-25 EP EP89900181A patent/EP0349621A1/de not_active Withdrawn
- 1988-11-28 IT IT8822760A patent/IT1227576B/it active
- 1988-11-28 FR FR888815505A patent/FR2623807B1/fr not_active Expired - Lifetime
- 1988-11-28 BE BE8801342A patent/BE1001327A3/fr not_active IP Right Cessation
- 1988-11-28 US US07/276,754 patent/US5010065A/en not_active Expired - Fee Related
-
1989
- 1989-07-18 GB GB8916355A patent/GB2231045B/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3740838A1 (de) | 1989-06-08 |
JPH02502379A (ja) | 1990-08-02 |
FR2623807A1 (fr) | 1989-06-02 |
WO1989004828A1 (en) | 1989-06-01 |
BE1001327A3 (fr) | 1989-09-26 |
IT1227576B (it) | 1991-04-16 |
IT8822760A0 (it) | 1988-11-28 |
EP0349621A1 (de) | 1990-01-10 |
US5010065A (en) | 1991-04-23 |
AT396687B (de) | 1993-11-25 |
CH677790A5 (de) | 1991-06-28 |
GB2231045A (en) | 1990-11-07 |
FR2623807B1 (fr) | 1990-08-31 |
GB2231045B (en) | 1992-04-29 |
GB8916355D0 (en) | 1990-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3770085D1 (de) | Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel. | |
DE68929361D1 (de) | Oligoribonukleotid-Derivate und Verwendung davon als Antiviral Arzneimittel | |
ATA98488A (de) | Pharmazeutische verwendung von 17-ketosteroiden | |
NZ220120A (en) | Heterocyclic benzamide derivatives and pharmaceutical composistions | |
ATA900296A (de) | Verwendung von n-glyoxylprolylesterverbindungen in arzneimitteln | |
KR890701675A (ko) | 포장의 개선 및 그 관련재료 | |
DE68914029D1 (de) | Arylmethylenderivate von Thiazolidinonen, Imidazolidinonen und Oxazolidininonen, nützlich als antiallergische Wirkstoffe und antiinflammatorische Wirkstoffe. | |
DE3765270D1 (de) | N-alpha-substituierte derivate von n-alpha-arylsulfonylaminoacyl-p-amidinophenylalaninamiden, deren herstellung, deren verwendung als arzneimittel und deren zwischenverbindungen. | |
DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
DE69033636D1 (de) | Verwendung von 4-Acyloxychinolin-Derivate als Insektizide und Akarizide | |
NO964758D0 (no) | Anvendelse av von Willebrand-faktor og farmasöytiske preparater | |
DE3784695D1 (de) | Gebrauch von gramineenextrakten als arzneimittel. | |
DE69726007D1 (de) | Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel | |
KR910700046A (ko) | 포르피린의 생산 및 용도 | |
DE3584370D1 (de) | Verwendung von podophyllotoxin und dessen derivaten. | |
DE3866737D1 (de) | Bisphosphonsaeure-derivate und sie enthaltende arzneimittel. | |
ATA901688A (de) | Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel | |
NO884566L (no) | Anvendelse av fluorderivater og kontrastpreparat for diagnostisering av ondartede neoplasmer. | |
DE69329933D1 (de) | 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel | |
NO890661D0 (no) | Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav. | |
DK95489D0 (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
DE3854981D1 (de) | 1-Pyrrolidinacetamid-Derivate und ihre Verwendung | |
ATA30594A (de) | Gereinigte form von streptograminen, ihre herstellung und sie enthaltende pharmazeutische massen | |
DE68919154D1 (de) | Benzodiazepinverbindungen und ihre Verwendung als Arzneimittel. | |
ATE9093T1 (de) | Benzodiazepinderivate und ihre verwendung als arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |